Mandate

Vinge advises BHG Group in connection with the acquisition of Hafa Bathroom Group

Vinge is advising BHG Group AB (publ) in connection with its acquisition of 94% of the shares in Hafa Bathroom Group.

Hafa Bathroom Group is Sweden’s largest privately-owned bathroom company with a market leading online platform. The company primarily sells products under the three trademarks of Hafa, NORO and Westerbergs and conducts operations in all of the Nordic countries and in the Baltic Region. During 2020, the turnover amounted to approximately MSEK 200 with good profitability.

BHG Group is the largest online actor within consumer trading in the Nordic Region and the largest actor in Europe within home improvement, which includes both Do It Yourself and Home Furnishing. BHG Group’s e-trading operations employ approximately 2,000 people and include more than 100 online destinations and 70 showrooms. The head office is situated in Malmö with operations in most European countries. BHG Group is listed on Nasdaq Stockholm.

The transaction is subject to customary approvals by public authorities.

Vinge’s team consisted of Kristian Ford together with, among others, Niklas Törnell, Lena Westberg, Julia Ahlqvist, Karin Gynnerstedt, Johanne Örnfeldt Svensson, Philip Åberg and Pär Remnelid (competition law).

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025